Literature DB >> 12147931

Use of lipid-lowering drugs and blood pressure control in patients with arterial hypertension.

Claudio Borghi1, Ada Dormi, Maddalena Veronesi, Vincenzo Immordino, Ettore Ambrosioni.   

Abstract

A large proportion of patients have both hypertension and hypercholesterolemia, two of the most important risk factors for cardiovascular diseases. Statins are the most widely used drugs for the treatment of plasma lipid abnormalities and have been reported to interact with elevated blood pressure. A reduction in blood pressure associated with the use of these agents has been reported in patients with untreated hypertension and in patients treated with antihypertensive drugs, particularly angiotensin-converting enzyme inhibitors and calcium channel blockers. This effect on blood pressure control has also been observed in diabetic patients. The mechanism responsible for the hypotensive effect seems to be largely independent of the effect of statins on plasma cholesterol, and probably is related to the interaction of the medications with endothelial function or angiotensin II receptors. The capacity of statins to improve blood pressure control may represent a useful tool for improvement in the prevention of cardiovascular diseases. Copyright 2002 Le Jacq Communications, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147931      PMCID: PMC8101886          DOI: 10.1111/j.1524-6175.2002.00499.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  45 in total

Review 1.  Current perspectives on statins.

Authors:  D J Maron; S Fazio; M F Linton
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

2.  Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.

Authors:  H Ide; S Fujiya; Y Aanuma; Y Agishi
Journal:  Clin Ther       Date:  1990 Sep-Oct       Impact factor: 3.393

3.  [Effect of fluvastatin on serum lipid levels in essential hypertension].

Authors:  Z Járai; J Kapocsi; C Farsang; K Detki; G Pados; Z Sebestyén; J Holló
Journal:  Orv Hetil       Date:  1996-08-25       Impact factor: 0.540

Review 4.  Antihypertensive drugs and reversing of endothelial dysfunction in hypertension.

Authors:  S Taddei; A Virdis; L Ghiadoni; I Sudano; A Salvetti
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

5.  Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

Authors:  J D Neaton; H Blackburn; D Jacobs; L Kuller; D J Lee; R Sherwin; J Shih; J Stamler; D Wentworth
Journal:  Arch Intern Med       Date:  1992-07

6.  Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin.

Authors:  J Muramatsu; A Kobayashi; N Hasegawa; S Yokouchi
Journal:  Atherosclerosis       Date:  1997-04       Impact factor: 5.162

7.  Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden.

Authors:  O Samuelsson; L Wilhelmsen; O K Andersson; K Pennert; G Berglund
Journal:  JAMA       Date:  1987-10-02       Impact factor: 56.272

8.  Simvastatin in the treatment of hypercholesterolemia in elderly patients.

Authors:  R Antonicelli; G Onorato; P Pagelli; L Pierazzoli; E Paciaroni
Journal:  Clin Ther       Date:  1990 Mar-Apr       Impact factor: 3.393

9.  Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension.

Authors:  R B D'Agostino; W B Kannel; M N Stepanians; L C D'Agostino
Journal:  Am J Cardiol       Date:  1993-01-01       Impact factor: 2.778

10.  Does lowering of cholesterol levels influence functional properties of large arteries?

Authors:  M Kool; F Lustermans; H Kragten; H Struijker Boudier; A Hoeks; R Reneman; H Rila; I Hoogendam; L Van Bortel
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more
  9 in total

Review 1.  The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.

Authors:  Zohreh Soltani; Vaughn Washco; Stephen Morse; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

2.  Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells.

Authors:  A Iwata; R Shirai; H Ishii; H Kushima; S Otani; K Hashinaga; K Umeki; K Kishi; I Tokimatsu; K Hiramatsu; J Kadota
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

3.  Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients.

Authors:  Roberto Fogari; Paola Preti; Annalisa Zoppi; Pierangelo Lazzari; Luca Corradi; Elena Fogari; Leonardina Ciccarelli; Giuseppe Derosa
Journal:  Eur J Clin Pharmacol       Date:  2006-08-02       Impact factor: 2.953

Review 4.  A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies.

Authors:  Adrian Bagust; Marc Evans; Sophie Beale; Philip D Home; Andrew S Perry; Murray Stewart
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  Effects of simvastatin on blood pressure in hypercholesterolemic patients: An open-label study in patients with hypertension or normotension.

Authors:  Adriana Branchi; Anna Maria Fiorenza; Adriana Torri; Cristina Berra; Emanuela Colombo; Angelo Rovellini; Domenico Sommariva
Journal:  Curr Ther Res Clin Exp       Date:  2004-05

6.  GGPP depletion initiates metaflammation through disequilibrating CYB5R3-dependent eicosanoid metabolism.

Authors:  Lisha Wei; Yan-Yan Zheng; Jie Sun; Pei Wang; Tao Tao; Yeqiong Li; Xin Chen; Yongjuan Sang; Danyang Chong; Wei Zhao; Yuwei Zhou; Ye Wang; Zhihui Jiang; Tiantian Qiu; Chao-Jun Li; Min-Sheng Zhu; Xuena Zhang
Journal:  J Biol Chem       Date:  2020-09-10       Impact factor: 5.157

7.  Baroreceptor Modulation of the Cardiovascular System, Pain, Consciousness, and Cognition.

Authors:  Heberto Suarez-Roca; Negmeldeen Mamoun; Martin I Sigurdson; William Maixner
Journal:  Compr Physiol       Date:  2021-02-12       Impact factor: 9.090

Review 8.  The Use of Dried Blood Spots for the Quantification of Antihypertensive Drugs.

Authors:  Alexander Chernonosov
Journal:  Int J Anal Chem       Date:  2018-08-01       Impact factor: 1.885

9.  Effect of simvastatin in the autonomic system is dependent on the increased gain/sensitivity of the baroreceptors.

Authors:  Edson D Moreira; Cristiano T Mostarda; Ivana C Moraes-Silva; Janaina B Ferreira; Fernando Dos Santos; Silvia Lacchini; Kátia De Angelis; Bruno Rodrigues; Maria Cláudia Irigoyen
Journal:  Physiol Rep       Date:  2013-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.